Aminopterin in Treating Patients With Refractory Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 1997

Study Completion Date

September 30, 2007

Conditions
Leukemia
Interventions
DRUG

aminopterin

DRUG

leucovorin calcium

Trial Locations (14)

10032

Herbert Irving Comprehensive Cancer Center, New York

11706

Medical & Clinical Research Associates, LLC, Bay Shore

20770

206 Research Associates, Greenbelt

20850

Mid Atlantic Clinical Research, Rockville

34239

Barzell, Whitmore, Treiman and Dunne - The Urology Treatment Center, Sarasota

60637

University of Chicago Cancer Research Center, Chicago

75230

Medical City Dallas Hospital, Dallas

75231

Urology Centers of North Texas, Dallas

78229

Urology San Antonio Research, San Antonio

92653

South Coast Urological Medical Group, Laguana Hills

92801

Advanced Urology Medical Center, Anaheim

98105

Children's Hospital and Regional Medical Center - Seattle, Seattle

06708

Urology Specialists, P.C., Waterbury

08901

Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00003305 - Aminopterin in Treating Patients With Refractory Leukemia | Biotech Hunter | Biotech Hunter